"At Chicago Cornea Consultants, you'll get world-class eye care that will change your life for the better. Our Hoffman Estates office offers a wide range of eye care services to the surrounding community. We offer LASIK surgery, cataract surgery, cornea transplants/cross-linking, BOTOX, and glaucoma treatments. If you or someone you know needs eye care or is looking for a new eye doctor then Chicago Cornea Consultants is the right place for you."

During the past decade, Chicago Cornea Consultants Ltd conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chicago Cornea Consultants Ltd" #1 sponsor was "Cxlusa" with 3 trials, followed by "Kala Pharmaceuticals, Inc." with 2 trials sponsored, "Ocugen" with 2 trials sponsored, "TearScience, Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chicago Cornea Consultants Ltd" #1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chicago Cornea Consultants Ltd" are "Dry Eye" (5 trials), "Keratoconus" (3 trials), "Blepharitis" (2 trials), "Degeneration" (2 trials) and "Dry Eye Syndromes" (2 trials). Many other conditions were trialed in "Chicago Cornea Consultants Ltd" in a lesser frequency.

Most popular intervention types in "Chicago Cornea Consultants Ltd" are "Drug" (16 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "0.005% Lacripep" (1 trials), "0.01% Lacripep" (1 trials), "0.5% Omaveloxolone Ophthalmic Suspension" (1 trials) and "1% Omaveloxolone Ophthalmic Suspension" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chicago Cornea Consultants Ltd" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Chicago Cornea Consultants Ltd". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Chicago Cornea Consultants Ltd, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Chicago Cornea Consultants Ltd, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".